stockrow
Friday 6 November 2026
Export QDEL’s income statement to Excel — free account
QuidelOrtho Corporation
QDEL Healthcare Medical Devices
QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +92.7%
- Free cash flow
- +120.7%
- Total debt
- +10.5%
Quarter to September 2026, against a year earlier
10.73
2.11
−16.43%
Follow QDEL
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 4 | 6 |
+8 more TTM periods Free account |
| (19.29%) | (45.91%) | (49.95%) | (46.15%) | ||
| (6.45%) | (17.34%) | (20.03%) | (18.56%) | ||
ROIC |
(1.75%) | (11.35%) | (13.97%) | (13.05%) | |
Return on Tangible Assets |
(21.69%) | (60.89%) | (69.04%) | (61.53%) | |
Average Days of Receivables |
52.85 | 48.04 | 49.44 | 55.75 | |
Free Cash Flow per Share |
(1.72) | (3.09) | (2.34) | (1.22) | |
Free Cash Flow |
(117.90) | (211.20) | (159.40) | (83.00) | |
Capital Expenditures |
(125.80) | (154.00) | (166.00) | (188.20) | |
| Other line items | |||||
Cash ROIC |
(2.41%) | (4.41%) | (3.41%) | (1.75%) | |
Accounts Receivable Turnover |
6.81 | 8.53 | 8.23 | 7.81 | |
Accounts Payable Turnover |
6.19 | 6.51 | 6.17 | 5.54 | |
Inventory Turnover |
2.30 | 2.47 | 2.49 | 2.62 | |
Average Days of Payables |
63.92 | 58.27 | 60.77 | 70.04 | |
Days of Inventory on Hand |
162.17 | 152.48 | 152.61 | 144.80 | |
Tax Rate |
0.10 | 0.02 | 0.03 | 0.02 | |
Research and Development Expense of Revenue |
7.01% | 6.76% | 6.70% | 6.82% | |
Selling, General and Administrative Expense of Revenue |
29.54% | 28.80% | 28.55% | 27.33% | |
Share Based Compensation of Revenue |
1.75% | 1.65% | 1.69% | 1.68% | |
Interest Coverage |
(0.60) | (4.06) | (5.21) | (5.18) | |
Operating CF/Net income |
(0.02) | 0.05 | (0.01) | (0.09) | |
Depreciation/Fixed assets |
0.00 | 0.87 | 0.86 | 0.84 | |
Capex/Depreciation |
0.00 | (0.13) | (0.14) | (0.16) | |
Revenue per Share |
37.75 | 39.15 | 38.96 | 40.27 | |
Operating CF per Share |
0.12 | (0.84) | 0.10 | 1.55 | |
Capex per Share |
(1.83) | (2.25) | (2.43) | (2.78) | |
Capex to Sales |
0.05 | 0.06 | 0.06 | 0.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026